SonoVue is a second-generation contrast agent that uses sulphur hexafluoride microbubbles for contrast-enhanced ultrasound imaging in adults. SonoVue is a low solubility gas contrast agent that allows ...

In most cases, the targeted microbubble contrast agents (MCAs) are fitted with a high-affinity targeting ligand. After the MCAs are adhered to the target, they begin to improve the acoustic signal ...

(MENAFN- Navistrat Analytics) Janauary 13, 2026- The growing incidence of chronic diseases is a major factor driving revenue growth in the microbubbles and ultrasound contrast agents market. According ...

ENSCHEDE, Netherlands & FAIRFIELD, N.J., July 7, 2021 /PRNewswire/ — Solstice Pharmaceuticals has successfully completed its latest round of funding to further the clinical development of its ...

A new contrast agent could allow real-time monitoring of pH changes in the body using an ultrasound scanner (ACS Sens. 2020, DOI: 10.1021/acssensors.0c00245). This expansion of the use of ultrasound ...

Primary liver cancer is the third cause of cancer death worldwide with 906,000 new cases and 830,000 deaths. Of these, 75-85% of patients are hepatocellular carcinoma (HCC), while the remaining 15-25% ...

Spinal cord injury (SCI) initiates a complex biological response and leads to the disruption of motor and sensory signals between the brain and the peripheral body at and below the level of damage.

Researchers at UT Southwestern have developed a first-of-its-kind ultrasound-guided cancer immunotherapy platform that delivers immune-stimulating agents to cells for the development of systemic ...

(MENAFN- Market Press Release) December 16, 2025 7:16 am - The Microbubbles/Ultrasound Contrast Agents market, valued at USD 1,542.6 million in 2024, is expected to ...

The diagnostics advisory committee reviewed the evidence on the clinical and cost effectiveness of contrast-enhanced ultrasound with SonoVue and noted that the technology was assessed in 3 clinical ...